Filing Details

Accession Number:
0001144204-15-014248
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-03-05 16:30:20
Reporting Period:
2015-03-03
Filing Date:
2015-03-05
Accepted Time:
2015-03-05 16:30:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1235007 Endocyte Inc ECYT Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1523662 Binh Nguyen 3000 Kent Ave, Suite A1-100
West Lafayette IN 47906
Vp Of Medical Affairs No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-03-03 40,000 $3.55 58,242 No 4 M Direct
Common Stock Disposition 2015-03-03 29,883 $5.79 28,359 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2015-03-03 40,000 $0.00 40,000 $3.55
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
20,000 2022-02-28 No 4 M Direct
Footnotes
  1. Shares sold to cover option exercise cost, taxes and fees.
  2. Represents the sale of 29,883 shares in multiple transactions, ranging in price from $5.72 to $5.91 per share, resulting in a weighted average sale price of $5.7888. The reporting person will provide, upon request by the SEC staff, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
  3. Shares subject to the option vest annually over a four (4) year period beginning on March 1, 2013.